Holen Sie sich die Stockscreener-App
6.78
2.45%
-0.17
Handel nachbörslich:
6.78
Schlusskurs vom Vortag:
$6.95
Offen:
$6.9
24-Stunden-Volumen:
315.77K
Relative Volume:
1.15
Marktkapitalisierung:
$257.89M
Einnahmen:
$239.40M
Nettoeinkommen (Verlust:
$104.44M
KGV:
2.2905
EPS:
2.96
Netto-Cashflow:
$-18.50M
1W Leistung:
-7.25%
1M Leistung:
+13.00%
6M Leistung:
-26.54%
1J Leistung:
-61.48%
1-Tages-Spanne:
$6.35
$6.94
1-Wochen-Bereich:
$6.35
$7.535
52-Wochen-Spanne:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Firmenname
Entrada Therapeutics Inc
Sektor
Branche
Telefon
857-305-1825
Adresse
ONE DESIGN CENTER PLACE, BOSTON
Vergleichen Sie TRDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
6.78 | 264.36M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-01-05 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-03 | Eingeleitet | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten
How risky is Entrada Therapeutics Inc. stock nowQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
Will Entrada Therapeutics Inc. stock gain from strong economy2025 Dividend Review & Growth-Oriented Investment Plans - newser.com
Real time pattern detection on Entrada Therapeutics Inc. stockQuarterly Profit Review & Smart Allocation Stock Tips - newser.com
Why Entrada Therapeutics Inc. stock is favored by pension fundsLayoff News & Verified Momentum Stock Alerts - newser.com
How Entrada Therapeutics Inc. stock benefits from strong dollarChart Signals & Reliable Price Action Trade Plans - newser.com
Understanding Entrada Therapeutics Inc.’s price movementPortfolio Risk Summary & AI Powered Market Trend Analysis - newser.com
Does Entrada Therapeutics Inc. stock trade at a discount to peersMarket Volume Summary & AI Driven Stock Movement Reports - newser.com
Applying sector rotation models to Entrada Therapeutics Inc.2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Multi factor analysis applied to Entrada Therapeutics Inc.CEO Change & Daily Entry Point Alerts - newser.com
Visualizing Entrada Therapeutics Inc. stock with heatmapsProfit Target & Risk Controlled Stock Alerts - newser.com
Applying big data sentiment scoring on Entrada Therapeutics Inc.Treasury Yields & Technical Analysis for Trade Confirmation - newser.com
Entrada Therapeutics Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Is Entrada Therapeutics Inc. forming a bottoming baseJuly 2025 Intraday Action & Accurate Trade Setup Notifications - newser.com
Entrada Therapeutics: Undervalued Leader in RNA Therapeutics with Promising DMD Pipeline - TipRanks
Using Python tools to backtest Entrada Therapeutics Inc. strategies2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
Entrada Therapeutics (TRDA) Expected to Announce Earnings on Tuesday - MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Analyzing Entrada Therapeutics Inc. with multi timeframe chartsEarnings Risk Report & Reliable Volume Spike Alerts - newser.com
Entrada Therapeutics to Present at Upcoming Investor Conferences - The Manila Times
Entrada (Nasdaq: TRDA) to present at Jefferies London and Evercore Miami conferences - Stock Titan
Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 7% – What’s Next? - Defense World
Published on: 2025-10-27 16:51:27 - newser.com
Published on: 2025-10-27 06:13:39 - newser.com
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):